Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Iteos Therapeutics Inc (NQ: ITOS ) 16.25 -0.41 (-2.46%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Iteos Therapeutics Inc < Previous 1 2 3 4 Next > iTeos to Participate in Upcoming Investor Conferences August 28, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Data at the European Society for Medical Oncology Congress 2024 August 20, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q2 2024 August 08, 2024 ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. Via InvestorPlace iTeos Reports Second Quarter 2024 Financial Results and Provides Business Updates August 08, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire Recap: ITeos Therapeutics Q4 Earnings March 06, 2024 Via Benzinga iTeos Therapeutics Announces Appointment of David Feltquate as Chief Medical Officer August 05, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Announces First Patient Dosed in GALAXIES Lung-301 Phase 3 Study, Earning $35 Million in Milestones from GSK July 08, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer June 17, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire 10 Health Care Stocks With Whale Alerts In Today's Session May 28, 2024 Via Benzinga ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q1 2024 May 10, 2024 ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 10, 2024 Via Benzinga Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday May 10, 2024 Via Benzinga Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings May 10, 2024 Via Benzinga Topics Stocks Exposures US Equities iTeos Reports First Quarter 2024 Financial Results and Provides Business Updates May 10, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Therapeutics Announces $120 Million Registered Direct Offering May 10, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Presents EOS-984 Preclinical Data Demonstrating Restoration of T Cell Activity from Adenosine Suppression at the American Association for Cancer Research Annual Meeting 2024 April 07, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire ITOS Stock Earnings: ITeos Therapeutics Beats EPS for Q4 2023 March 06, 2024 ITOS stock results show that ITeos Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. Via InvestorPlace iTeos Appoints Oncology Veteran Jill DeSimone to Its Board of Directors March 06, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates March 06, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Highlight Preclinical Data on First-In-Class EOS-984 Targeting ENT1 at the American Association for Cancer Research Annual Meeting 2024 March 05, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Participate in Upcoming Investor Conferences March 01, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Announces 2024 Strategic Priorities and Anticipated Milestones January 08, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at the 42nd Annual J.P. Morgan Healthcare Conference January 03, 2024 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos to Present at the Piper Sandler 35th Annual Healthcare Conference November 21, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire iTeos Reports Third Quarter 2023 Financial Results and Provides Business Updates November 07, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 17, 2023 Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc. Via Benzinga Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday October 17, 2023 U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Over $5M Bet On Asana? Check Out These 3 Stocks Insiders Are Buying October 13, 2023 Although U.S. stocks closed lower on Thursday following the CPI data, there were a few notable insider trades. Via Benzinga iTeos to Participate in Upcoming Investor Conferences September 06, 2023 From iTeos Therapeutics Inc. Via GlobeNewswire < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.